Long-Term Effects of CS-514 on Serum Lipoprotein Lipid and Apolipoprotein Levels in Patients with Familial Hypercholesterolemia
- 1 January 1987
- book chapter
- Published by Springer Nature in Proceedings in Life Sciences
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemiaMetabolism, 1987
- HUMAN APOLIPOPROTEIN MOLECULAR BIOLOGY AND GENETIC VARIATIONAnnual Review of Biochemistry, 1985
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Atherogenic Hyperlipoproteinemia: The Cellular and Molecular Biology of Plasma Lipoproteins Altered by Dietary Fat and CholesterolMedical Clinics of North America, 1982
- Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.Circulation, 1981
- Effects of an Inhibitor of 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase on Serum Lipoproteins and Ubiquinone-10 Levels in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1981
- Regulation of Plasma Cholesterol by Lipoprotein ReceptorsScience, 1981
- Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog.Proceedings of the National Academy of Sciences, 1981